Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

CollPlant Biotechnologies (CLGN) Net Income towards Common Stockholders (2017 - 2025)

Historic Net Income towards Common Stockholders for CollPlant Biotechnologies (CLGN) over the last 9 years, with Q3 2025 value amounting to -$3.5 million.

  • CollPlant Biotechnologies' Net Income towards Common Stockholders rose 2278.73% to -$3.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.7 million, marking a year-over-year decrease of 20342.86%. This contributed to the annual value of -$16.5 million for FY2024, which is 14558.3% down from last year.
  • Latest data reveals that CollPlant Biotechnologies reported Net Income towards Common Stockholders of -$3.5 million as of Q3 2025, which was up 2278.73% from $3.2 million recorded in Q2 2025.
  • In the past 5 years, CollPlant Biotechnologies' Net Income towards Common Stockholders registered a high of $71.9 million during Q3 2021, and its lowest value of -$192.6 million during Q4 2021.
  • In the last 5 years, CollPlant Biotechnologies' Net Income towards Common Stockholders had a median value of -$3.0 million in 2021 and averaged -$6.4 million.
  • The largest annual percentage gain for CollPlant Biotechnologies' Net Income towards Common Stockholders in the last 5 years was 69875.44% (2021), contrasted with its biggest fall of 52956.61% (2021).
  • Over the past 5 years, CollPlant Biotechnologies' Net Income towards Common Stockholders (Quarter) stood at -$192.6 million in 2021, then surged by 97.57% to -$4.7 million in 2022, then fell by 8.38% to -$5.1 million in 2023, then rose by 21.59% to -$4.0 million in 2024, then grew by 11.75% to -$3.5 million in 2025.
  • Its Net Income towards Common Stockholders was -$3.5 million in Q3 2025, compared to $3.2 million in Q2 2025 and $1.6 million in Q1 2025.